ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2017

The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure.

Markku S Nieminen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.